Indication
Hormone-sensitive Prostate Cancer
2 clinical trials
3 products
Clinical trial
Clinical Studies Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets (Single-center, Randomized, Open-label, Crossover)Status: Completed, Estimated PCD: 2023-06-09
Product
SHR7280Clinical trial
A Multicenter, Randomized, Double-blind Phase Ib/III Clinical Study of Dalpiciclib Isethionate Tablets Combined With Abiraterone Acetate Tablets (I) and Prednisone Tablets (AA-P) Versus Placebo Combined With AA-P in Treatment of High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC).Status: Not yet recruiting, Estimated PCD: 2028-12-01
Product
Abiraterone acetateProduct
Dalpiciclib